Market Movers: Tata Steel's Green Push, Aurobindo's FDA Inspection, and NTPC's Nuclear Venture

Tata Steel secures £500 million UK grant for green steelmaking at Port Talbot, preserving 5,000 jobs. Aurobindo Pharma faces FDA scrutiny with 5 observations at its Andhra Pradesh facility. NTPC incorporates wholly-owned subsidiary for nuclear energy initiatives. Vedanta's demerger plan receives 83% creditor approval. L&T acquires remaining 26% stake in L&T Special Steels from NPCIL. These developments signal significant shifts in India's industrial landscape, with companies focusing on sustainability, regulatory compliance, and strategic restructuring to drive growth and efficiency in a challenging global market.

Sources: Moneycontrol, Business Standard, Financial Express